Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1

Mark E Pepin1, Christoph Koentges2, Katharina Pfeil3

  • 1Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.

Insights

Adiponectin receptor 1 (AdipoR1) signaling impacts mitochondrial protein composition in the heart, kidneys, and liver. Disruptions in AdipoR1 signaling affect oxidative phosphorylation, a key process in diabetic complications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Decreased adiponectin levels in type 2 diabetes are linked to mitochondrial dysfunction.
  • This dysfunction impairs key signaling pathways like AMPK-SIRT1-PGC-1α.
  • Adiponectin receptor 1 (AdipoR1) signaling is implicated in this process.

Purpose of the Study:

  • To investigate the role of disrupted AdipoR1 signaling in mitochondrial protein composition.
  • To examine cardiac, renal, and hepatic tissues affected by diabetic complications.
  • To understand the tissue-specific and conserved effects of AdipoR1 deficiency.

Main Methods:

  • Comparative proteomics was used on mitochondria from AdipoR1 knockout (Adipor1-/-) mice.
  • Mitochondria were isolated from cardiac, renal, and hepatic tissues.
  • Gene expression analysis was performed in high fat-fed mice.

Main Results:

  • Significant numbers of differentially regulated mitochondrial proteins were identified in each tissue.
  • Oxidative phosphorylation proteins were disproportionately affected across tissues.
  • NRF1 was identified as a conserved downregulated regulator in both knockout and diet-induced models.

Conclusions:

  • AdipoR1 signaling regulates mitochondrial protein composition in a conserved yet distinct manner across tissues.
  • Impaired AdipoR1 signaling affects oxidative phosphorylation, contributing to diabetic complications.
  • NRF1 may represent a common regulatory mechanism in AdipoR1-related mitochondrial dysfunction.